Last €3.96 EUR
Change Today +0.024 / 0.61%
Volume 4.0K
MED On Other Exchanges
As of 1:47 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

mediclin ag (MED) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/4/13 - €4.62
52 Week Low
07/11/14 - €3.85
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDICLIN AG (MED)

Related News

No related news articles were found.

mediclin ag (MED) Related Businessweek News

No Related Businessweek News Found

mediclin ag (MED) Details

MEDICLIN Aktiengesellschaft operates hospitals and provides services in the areas of neurosciences, psychological sciences, and orthopedics in Germany. The company’s Post-Acute segment offers services in the fields of subsequent nursing treatment and curative procedures. This segment’s subsequent nursing treatment includes various medical measures required to facilitate the healing process and return the patient to a functioning state after acute care treatment; and curative treatment comprises prophylactic measures against the occurrence or reoccurrence of illnesses. Its Acute segment encompasses medical offerings focusing on neurology and neurological early rehabilitation, as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. This segment also offers services in the areas of cardiology, oncology, and ENT; and provides acute outpatient services. The company’s Other activities segment offers full-time and short-term nursing care; and outpatient nursing care in the nursing care facilities. MEDICLIN Aktiengesellschaft operates 34 clinics, 7 nursing care facilities, and 11 medical care centers with a total capacity of approximately 8,100 beds in 11 German federal states. The company is headquartered in Offenburg, Germany.

8,500 Employees
Last Reported Date: 03/18/14

mediclin ag (MED) Top Compensated Officers

Chief Financial Officer and Member of the Man...
Total Annual Compensation: €324.7K
Compensation as of Fiscal Year 2013.

mediclin ag (MED) Key Developments

Mediclin AG Reports Group Earnings Results for the First Quarter of 2014

Mediclin AG reported group earnings results for the first quarter of 2014. For the quarter, the company reported cash flow from operative activities of EUR 4.1 million against cash flow used in operative activities of EUR 5.8 million a year ago. Undiluted loss per share was EUR 0.04 against EUR 0.14 a year ago.

Mediclin AG Reports Group Earnings Results for the First Quarter of 2014

Mediclin AG reported group earnings results for the first quarter of 2014. For the quarter, the company reported sales in the amount of EUR 132.4 million against EUR 124.5 million a year ago, thus being EUR 7.9 million or 6.4% above the value of the first quarter 2013. All segments contributed to sales increase. The occupancy rate of the Group improved to 86.1% against 83.9% of previous year. In comparison with the previous year the group operating result improved by EUR 4.9 million from operating loss of EUR 5.9 million to EUR 1.0 million. The loss on financial result was EUR 1.0 million against EUR 0.8 million. The result after tax attributable to shareholders of the company improved by EUR 4.8 million from loss after tax attributable to shareholders of EUR 6.5 million to EUR 1.7 million.

Mediclin AG Reports Preliminary Group Earnings Results for 2013

Mediclin AG reported preliminary Group earnings results for 2013. For the period, the company achieved group sales of EUR 514.9 million compared with EUR 509.7 million for the same period last year. The preliminary Group operating result accounts for EUR 2.2 million compared with EUR 4.3 million for the same period last year.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MED:GR €3.96 EUR +0.024

MED Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MED.
View Industry Companies

Industry Analysis


Industry Average

Valuation MED Industry Range
Price/Earnings 90.5x
Price/Sales 0.4x
Price/Book 1.3x
Price/Cash Flow 6.9x
TEV/Sales 0.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICLIN AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at